SCHEMBL7990557

SCHEMBL7990557

COC[C@@H](C)C/C=C/c1cc(C)ccc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
L3MBTL4 Q8NA19 1/20 0.38
L3MBTL3 Q96JM7 1/20 0.38
ALDH1A1 P00352 5/20 0.37
CYP3A4 P08684 1/20 0.37
POLB P06746 2/20 0.36
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
MAPT P10636 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
USP2 O75604 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7990406 1.00 ACHE (0.40) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7998464 0.86 ACHE (0.38) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7990258 0.86 ACHE (0.38) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7998889 0.85 L3MBTL4 (0.38) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7989766 0.85 L3MBTL4 (0.38) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7990256 0.82 ACHE (0.42) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7990251 0.82 ACHE (0.42) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7989791 0.79 ACHE (0.42) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7990260 0.79 ACHE (0.42) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL8000126 0.79 ACHE (0.44) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117594-A1 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-09-24 WO disclosed